Low-Intensity Extracorporeal Shockwave Therapy (LI-ESWT) in Renal Diseases: A Review of Animal and Human Studies

References

• Burneikaite G, Shkolnik E, Celutkiene J, et al. Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis. Cardiovasc Ultrasound. 2017;15(1):11. doi:10.1186/s12947-017-0102-y
   PubMedGoogle Scholar
• Cayton T, Harwood A, Smith GE, Chetter I. A systematic review of extracorporeal shockwave therapy as a novel treatment for intermittent claudication. Ann Vasc Surg. 2016;35:226–233. doi:10.1016/j.avsg.2016.02.017
   PubMed Web of Science ®Google Scholar
• Huang Q, Yan P, Xiong H, et al. Extracorporeal shock wave therapy for treating foot ulcers in adults with type 1 and type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Can J Diabetes. 2019;2019:1.
   Google Scholar
• Sokolakis I, Hatzichristodoulou G. Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials. Int J Impot Res. 2019;31(3):177–194. doi:10.1038/s41443-019-0117-z
   PubMed Web of Science ®Google Scholar
• d’Agostino MC, Craig K, Tibalt E, Respizzi S. Shock wave as biological therapeutic tool: from mechanical stimulation to recovery and healing, through mechanotransduction. Int J Surg. 2015;24(PtB):147–153. doi:10.1016/j.ijsu.2015.11.030
   PubMed Web of Science ®Google Scholar
• Hatanaka K, Ito K, Shindo T, et al. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction. Am J Physiol Cell Physiol. 2016;311(3):C378–85. doi:10.1152/ajpcell.00152.2016
   PubMed Web of Science ®Google Scholar
• Peng YZ, Zheng K, Yang P, et al. Shock wave treatment enhances endothelial proliferation via autocrine vascular endothelial growth factor. Genet Mol Res. 2015;14(4):19203–19210. doi:10.4238/2015.December.29.30
   PubMed Web of Science ®Google Scholar
• Yan X, Zeng B, Chai Y, Luo C, Li X. Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann Plast Surg. 2008;61(6):646–653. doi:10.1097/SAP.0b013e318172ba1f
   PubMed Web of Science ®Google Scholar
• DIGEST. Guidelines for extracorporeal shock wave therapy. The International Society for Medical Shockwave Treatment; 2019. Available from: https://www.shockwavetherapy.org/fileadmin/user_upload/ISMST_Guidelines.pdf:. Accessed February 3, 2023.
   Google Scholar
• Caron J, Michel PA, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ. Extracorporeal shock wave therapy does not improve hypertensive nephropathy. Physiol Rep. 2016;4:11. doi:10.14814/phy2.12699
   Google Scholar
• Zhang X, Krier JD, Amador Carrascal C, et al. Low-energy shockwave therapy improves ischemic kidney microcirculation. J Am Soc Nephrol. 2016;27(12):3715–3724. doi:10.1681/ASN.2015060704
   PubMed Web of Science ®Google Scholar
• Xue Y, Xu Z, Chen H, Gan W, Chong T. Low-energy shock wave preconditioning reduces renal ischemic reperfusion injury caused by renal artery occlusion. Acta Cir Bras. 2017;32(7):550–558. doi:10.1590/s0102-865020170070000006
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu X, Ferguson CM, et al. Magnetic resonance elastography can monitor changes in medullary stiffness in response to treatment in the swine ischemic kidney. MAGMA. 2018;31(3):375–382. doi:10.1007/s10334-017-0671-7
   PubMedGoogle Scholar
• Chen XJ, Zhang X, Jiang K, et al. Improved renal outcomes after revascularization of the stenotic renal artery in pigs by prior treatment with low-energy extracorporeal shockwave therapy. J Hypertens. 2019;37:2074–2082. doi:10.1097/HJH.0000000000002158
   PubMed Web of Science ®Google Scholar
• Hsiao CC, Huang WH, Cheng KH, Lee CT. Low-energy extracorporeal shock wave therapy ameliorates kidney function in diabetic nephropathy. Oxid Med Cell Longev. 2019;2019:8259645. doi:10.1155/2019/8259645
   PubMed Web of Science ®Google Scholar
• Sung PH, Chen KH, Li YC, Chiang JY, Lee MS, Yip HK. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition. Biomed Pharmacother. 2019;111:1088–1102. doi:10.1016/j.biopha.2019.01.025
   PubMed Web of Science ®Google Scholar
• Yoshida M, Nakamichi T, Mori T, Ito K, Shimokawa H, Ito S. Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats. Clin Exp Nephrol. 2019;23(5):597–605. doi:10.1007/s10157-019-01689-7
   PubMed Web of Science ®Google Scholar
• Zhao Y, Santelli A, Zhu XY, et al. Low-energy shockwave treatment promotes endothelial progenitor cell homing to the stenotic pig kidney. Cell Transplant. 2020;29:963689720917342. doi:10.1177/0963689720917342
   PubMed Web of Science ®Google Scholar
• Chen XJ, Zhang X, Jiang K, et al. Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy. J Cell Physiol. 2020;235:9806–9818. doi:10.1002/jcp.29794
   PubMed Web of Science ®Google Scholar
• Liu J, Dou Q, Zhou C, et al. Low-energy shock wave pretreatment recruit circulating endothelial progenitor cells to attenuate renal ischaemia reperfusion injury. J Cell Mol Med. 2020;24(18):10589–10603. doi:10.1111/jcmm.15678
   PubMed Web of Science ®Google Scholar
• Skov-Jeppesen SM, Yderstraede KB, Bistrup C, et al. Low-intensity shockwave therapy in the treatment of diabetic nephropathy: a prospective Phase 1 study. Nephrol Dial Transplant. 2018;2018:1.
   Google Scholar
• Skov-Jeppesen SM, Yderstraede KB, Jensen BL, Bistrup C, Hanna M, Lund L. Low-Intensity Shockwave Therapy (LI-ESWT) in diabetic kidney disease: results from an open-label interventional clinical trial. Int J Nephrol Renovasc Dis. 2021;14:255–266. doi:10.2147/IJNRD.S315143
   PubMed Web of Science ®Google Scholar
• Michel PA, Bonin P, Bige N, et al. Effects of shock wave therapy in chronic kidney diseases. Nephron Physiol. 2011;1:p12.
   Google Scholar
• Hanna M, Pedersen D, Lund M, Marcussen N, Lund L. Low energy ESWT, a novel treatment for diabetic nephropathy (animal study). J Endourol. 2012;1:A6.
   Google Scholar
• Lundrup RN, Skov-Jeppesen SM, Bistrup C, Jensen B, Yderstraede K, Lund L. Safety and effect of low-energy extracorporeal shockwave therapy (ESWT) on the renal allograft in transplant recipients-preliminary results. Scand J Urol. 2019;53(Supplement 221):4.
   Google Scholar
• Aleksandre B, Andro D, Milad H, et al. Low intensity shock waves in the treatment of diabetic nephropathy: prospective, phase 1 study, Georgian arm. Eur Urol Suppl. 2019;18(12):e3635–e6. doi:10.1016/S1569-9056(19)35038-9
   Google Scholar
• Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet. 1980;2(8207):1265–1268. doi:10.1016/S0140-6736(80)92335-1
   PubMed Web of Science ®Google Scholar
• Ha CH, Kim S, Chung J, An SH, Kwon K. Extracorporeal shock wave stimulates expression of the angiogenic genes via mechanosensory complex in endothelial cells: mimetic effect of fluid shear stress in endothelial cells. Int J Cardiol. 2013;168(4):4168–4177. doi:10.1016/j.ijcard.2013.07.112
   PubMed Web of Science ®Google Scholar
• Holfeld J, Tepekoylu C, Reissig C, et al. Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle. Cardiovasc Res. 2016;109(2):331–343. doi:10.1093/cvr/cvv272
   PubMed Web of Science ®Google Scholar
• Weihs AM, Fuchs C, Teuschl AH, et al. Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation. J Biol Chem. 2014;289(39):27090–27104. doi:10.1074/jbc.M114.580936
   PubMed Web of Science ®Google Scholar
• Holfeld J, Zimpfer D, Albrecht-Schgoer K, et al. Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart disease. J Tissue Eng Regen Med. 2014;2014:1.
   Google Scholar
• Cai HY, Li L, Guo T, et al. Cardiac shockwave therapy improves myocardial function in patients with refractory coronary artery disease by promoting VEGF and IL-8 secretion to mediate the proliferation of endothelial progenitor cells. Exp Ther Med. 2015;10(6):2410–2416. doi:10.3892/etm.2015.2820
   PubMed Web of Science ®Google Scholar
• Jeong HC, Jeon SH, Qun ZG, et al. Effects of next-generation low-energy extracorporeal shockwave therapy on erectile dysfunction in an animal model of diabetes. World J Mens Health. 2017;35(3):186–195. doi:10.5534/wjmh.17024
   PubMedGoogle Scholar
• Wang CJ, Ko JY, Kuo YR, Yang YJ. Molecular changes in diabetic foot ulcers. Diabetes Res Clin Pract. 2011;94(1):105–110. doi:10.1016/j.diabres.2011.06.016
   PubMed Web of Science ®Google Scholar
• Holfeld J, Tepekoylu C, Blunder S, et al. Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation. PLoS One. 2014;9(8):e103982. doi:10.1371/journal.pone.0103982
   PubMed Web of Science ®Google Scholar
• Kaller M, Faber L, Bogunovic N, Horstkotte D, Burchert W, Lindner O. Cardiac shock wave therapy and myocardial perfusion in severe coronary artery disease. Clin Res Cardiol. 2015;104(10):843–849. doi:10.1007/s00392-015-0853-0
   PubMed Web of Science ®Google Scholar
• Wang CJ, Wu RW, Yang YJ. Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Res Clin Pract. 2011;92(2):187–193. doi:10.1016/j.diabres.2011.01.019
   PubMed Web of Science ®Google Scholar
• Jeppesen SM, Yderstraede KB, Rasmussen BS, Hanna M, Lund L. Extracorporeal shockwave therapy in the treatment of chronic diabetic foot ulcers: a prospective randomised trial. J Wound Care. 2016;25(11):641–649. doi:10.12968/jowc.2016.25.11.641
   PubMed Web of Science ®Google Scholar
• Park JK, Cui Y, Kim MK, et al. Effects of extracorporeal shock wave lithotripsy on plasma levels of nitric oxide and cyclic nucleotides in human subjects. J Urol. 2002;168(1):38–42. doi:10.1016/S0022-5347(05)64827-6
   PubMed Web of Science ®Google Scholar
• Sarica K, Balat A, Erbagci A, Cekmen M, Yurekli M, Yagci F. Effects of shock wave lithotripsy on plasma and urinary levels of nitrite and adrenomedullin. Urol Res. 2003;31(5):347–351. doi:10.1007/s00240-003-0351-0
   PubMedGoogle Scholar
• Aksoy H, Aksoy Y, Turhan H, Keleş S, Ziypak T, Ozbey I. The effect of shock wave lithotripsy on nitric oxide and malondialdehyde levels in plasma and urine samples. Cell Biochem Funct. 2007;25(5):533–536. doi:10.1002/cbf.1349
   PubMed Web of Science ®Google Scholar
• Sukubo NG, Tibalt E, Respizzi S, Locati M, d’Agostino MC. Effect of shock waves on macrophages: a possible role in tissue regeneration and remodeling. Int J Surg. 2015;24:124–130. doi:10.1016/j.ijsu.2015.07.719
   PubMed Web of Science ®Google Scholar
• Davis TA, Stojadinovic A, Anam K, et al. Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury. Int Wound J. 2009;6(1):11–21. doi:10.1111/j.1742-481X.2008.00540.x
   PubMed Web of Science ®Google Scholar
• Abe Y, Ito K, Hao K, et al. Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circ J. 2014;2014:1.
   Google Scholar
• Fu M, Sun CK, Lin YC, et al. Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment. PLoS One. 2011;6(9):e24342. doi:10.1371/journal.pone.0024342
   PubMed Web of Science ®Google Scholar
• Lei PP, Tao SM, Shuai Q, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial fibrosis by decreasing the amount of fibrocytes after acute myocardial infarction in pigs. Coron Artery Dis. 2013;24(6):509–515. doi:10.1097/MCA.0b013e3283640ec7
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation. 2006;114(25):2823–2830. doi:10.1161/CIRCULATIONAHA.106.628623
   PubMed Web of Science ®Google Scholar
• Assmus B, Walter DH, Seeger FH, et al. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA. 2013;309(15):1622–1631. doi:10.1001/jama.2013.3527
   PubMed Web of Science ®Google Scholar
• Gollmann-Tepekoylu C, Lobenwein D, Theurl M, et al. Shock wave therapy improves cardiac function in a model of chronic ischemic heart failure: evidence for a mechanism Involving VEGF signaling and the extracellular matrix. J Am Heart Assoc. 2018;7(20):e010025. doi:10.1161/JAHA.118.010025
   PubMed Web of Science ®Google Scholar
• Kraemer R, Sorg H, Forstmeier V, et al. Immediate dose-response effect of high-energy versus low-energy extracorporeal shock wave therapy on cutaneous microcirculation. Ultrasound Med Biol. 2016;42(12):2975–2982. doi:10.1016/j.ultrasmedbio.2016.08.010
   PubMed Web of Science ®Google Scholar
• Kamelger F, Oehlbauer M, Piza-Katzer H, Meirer R. Extracorporeal shock wave treatment in ischemic tissues: what is the appropriate number of shock wave impulses? J Reconstr Microsurg. 2010;26(2):117–121. doi:10.1055/s-0029-1243296
   PubMed Web of Science ®Google Scholar
• Zins SR, Amare MF, Tadaki DK, Elster EA, Davis TA. Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy. Angiogenesis. 2010;13(4):293–304. doi:10.1007/s10456-010-9186-9
   PubMed Web of Science ®Google Scholar
• Mittermayr R, Hartinger J, Antonic V, et al. Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Ann Surg. 2011;253(5):1024–1032. doi:10.1097/SLA.0b013e3182121d6e
   PubMed Web of Science ®Google Scholar